Efficacy and safety of remdesivir in COVID-19 caused by SARS-CoV-2: a systematic review and meta-analysis | BMJ Open

https://bmjopen.bmj.com/content/11/6/e048416

Christine Peters: Covid-19 is airborne, so what needs to happen next? - The BMJ

https://blogs.bmj.com/bmj/2021/06/25/christine-peters-covid-19-is-airborne-so-what-needs-to-happen-next/


Enviado desde mi iPhone

Why Uruguay lost control of COVID

https://www.nature.com/articles/d41586-021-01714-4


Enviado desde mi iPhone

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial - The Lancet

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01420-3/fulltext


Enviado desde mi iPhone

New national surveillance of possible COVID-19 reinfection, published by PHE - GOV.UK

https://www.gov.uk/government/news/new-national-surveillance-of-possible-covid-19-reinfection-published-by-phe


Enviado desde mi iPhone

Treating Sleep Apnea Lowers MI, Stroke Risk

https://www.medscape.com/viewarticle/953265


Enviado desde mi iPhone

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum: Cell

https://www.cell.com/cell/fulltext/S0092-8674(21)00755-8

Delta Variant Doubles Hospitalisation Risk, Infection Rates Declining in Europe: COVID-19 Global Weekly Highlights

https://www.medscape.com/viewarticle/953269

Causation or confounding: why controls are critical for characterizing long COVID | Nature Medicine

https://www.nature.com/articles/s41591-021-01402-w

Antibody and B cell responses to SARS-CoV-2 infection and vaccination: Cell Host & Microbe

https://www.cell.com/cell-host-microbe/fulltext/S1931-3128(21)00287-0

‘Diagnostic downshift’: clinical and system consequences of extrapolating secondary care testing tactics to primary care | BMJ Evidence-Based Medicine

https://ebm.bmj.com/content/early/2021/06/07/bmjebm-2020-111629


Enviado desde mi iPhone

Covid: Is there a limit to how much worse variants can get? - BBC News

https://www.bbc.com/news/health-57431420

BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants | Nature

https://www.nature.com/articles/s41586-021-03693-y

Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans | Nature

https://www.nature.com/articles/s41586-021-03681-2


Enviado desde mi iPhone

The four most urgent questions about long COVID

https://www.nature.com/articles/d41586-021-01511-z

Vacuna urgencias ingresos.

https://www.cdc.gov/mmwr/volumes/70/wr/mm7023e2.htm?s_cid=mm7023e2_w&s=03 

Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial - The Lancet

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01203-4/fulltext

When You’ve Been Fully Vaccinated | CDC

https://www.cdc.gov/coronavirus/2019-ncov/vaccines/fully-vaccinated.html


Enviado desde mi iPhone

Spread of a SARS-CoV-2 variant through Europe in the summer of 2020 | Nature

https://www.nature.com/articles/s41586-021-03677-y


Enviado desde mi iPhone

SARS-CoV-2 Variant Classifications and Definitions

https://www.cdc.gov/coronavirus/2019-ncov/variants/variant-info.html#Concern

The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies: Cell

https://www.cell.com/cell/fulltext/S0092-8674(21)00703-0

Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study | The BMJ

https://www.bmj.com/content/373/bmj.n1098?ijkey=55726cd45df596eb54a9c9e3f4439a0b2d633547&keytype2=tf_ipsecsha

RV: Respuesta inmune combinacion de vacunas.

 

 

Pre-print. Estudio de cohortes de comparación directa respuesta humoral y celular #SARSCoV2 y VoC. Cohorte CoCo.

Dr Pablo Guisado Vasco MD, PhD

@PabloGVasco

 

 

- ChAD/ChAD vs ChAD/Pfizer: buena respuesta inmune - Heterologa: similar a BNT/BNT - ChAD/Pfizer: mayor respuesta inmune celular y humoral

 

https://www.researchsquare.com/article/rs-580444/v1

uso de antibacterianos en covid poco utiles.

News

Covid-19: Antimicrobial use was high during first wave despite bacterial co-infections being rare, study finds

https://www.bmj.com/content/373/bmj.n1427.short?rss=1&utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+bmj%2Frecent+%28Latest+from+BMJ%29

Medidas de frecuencia de enfermedad.

https://www.fisterra.com/mbe/investiga/medidas_frecuencia/med_frec2.pdf